1. Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials. Issue 2 (3rd December 2012) Authors: Ratner, R. E.; Gough, S. C. L.; Mathieu, C.; Del Prato, S.; Bode, B.; Mersebach, H.; Endahl, L.; Zinman, B. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 2(2013:Feb.) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST® T1). Issue 2 (19th February 2016) Authors: Hirsch, I. B.; Franek, E.; Mersebach, H.; Bardtrum, L.; Hermansen, K. Journal: Diabetic medicine Issue: Volume 34:Issue 2(2017) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗